| Dr Daniel Lloyd Wegg, MD | |
|
386 Symmes Center Dr Ste 1, Winchester, IN 47394-9402 | |
| (765) 857-2523 | |
| (765) 857-2304 |
| Full Name | Dr Daniel Lloyd Wegg |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 47 Years |
| Location | 386 Symmes Center Dr Ste 1, Winchester, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013909241 | NPI | - | NPPES |
| 2029692 | Medicaid | OH | |
| 200045790 | Medicaid | IN | |
| 000000836404 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 01043837A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reid-anc Home Care Services Llc | Richmond, IN | Home health agency |
| Home Health Angels Llc | Winchester, IN | Home health agency |
| Reid Hospital & Health Care Services | Richmond, IN | Hospital |
| Ascension St Vincent Randolph | Winchester, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Indiana University Health Jay, Inc. | Portland, IN | Hospital |
| Randolph Nursing Home | Winchester, IN | Nursing home |
| Pineknoll Rehabilitation Centre | Winchester, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reid Physician Associates, Inc. | 6406910769 | 338 |
News Archive
Promising new research provides evidence that ALS, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be treatable using neural stem cells.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Today's major health policy headlines include reports about the latest developments in Virginia's court challenge against the health law, a U.S. government lawsuit targeting Michigan Blue Cross Blue Shield for anti-trust activities and a study about the Department of Health and Human Services' Hospital Compare.
Academic health center CEOs told congressional staff and representatives of national health care organizations at a congressional briefing that pending health reform legislation does not yet reflect the strategic emphasis on health workforce needed to implement successful health system reform.
› Verified 9 days ago
| Entity Name | Reid Physician Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265689111 PECOS PAC ID: 6406910769 Enrollment ID: O20090130000573 |
News Archive
Promising new research provides evidence that ALS, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be treatable using neural stem cells.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Today's major health policy headlines include reports about the latest developments in Virginia's court challenge against the health law, a U.S. government lawsuit targeting Michigan Blue Cross Blue Shield for anti-trust activities and a study about the Department of Health and Human Services' Hospital Compare.
Academic health center CEOs told congressional staff and representatives of national health care organizations at a congressional briefing that pending health reform legislation does not yet reflect the strategic emphasis on health workforce needed to implement successful health system reform.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Lloyd Wegg, MD 1100 Reid Pkwy, Medical Staff Services, Richmond, IN 47374-1157 Ph: (765) 857-2523 | Dr Daniel Lloyd Wegg, MD 386 Symmes Center Dr Ste 1, Winchester, IN 47394-9402 Ph: (765) 857-2523 |
News Archive
Promising new research provides evidence that ALS, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be treatable using neural stem cells.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Today's major health policy headlines include reports about the latest developments in Virginia's court challenge against the health law, a U.S. government lawsuit targeting Michigan Blue Cross Blue Shield for anti-trust activities and a study about the Department of Health and Human Services' Hospital Compare.
Academic health center CEOs told congressional staff and representatives of national health care organizations at a congressional briefing that pending health reform legislation does not yet reflect the strategic emphasis on health workforce needed to implement successful health system reform.
› Verified 9 days ago